Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Current Deferred Revenue (2022 - 2026)

Core Laboratories filings provide 5 years of Current Deferred Revenue readings, the most recent being $4.7 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue fell 51.82% to $4.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.7 million, a 51.82% decrease, with the full-year FY2025 number at $5.6 million, down 40.51% from a year prior.
  • Current Deferred Revenue hit $4.7 million in Q1 2026 for Core Laboratories, down from $5.6 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $9.8 million in Q1 2025 to a low of $4.6 million in Q3 2023.
  • Median Current Deferred Revenue over the past 5 years was $5.6 million (2025), compared with a mean of $6.5 million.
  • Biggest five-year swings in Current Deferred Revenue: soared 96.26% in 2024 and later crashed 51.82% in 2026.
  • Core Laboratories' Current Deferred Revenue stood at $5.9 million in 2022, then fell by 19.98% to $4.8 million in 2023, then soared by 96.26% to $9.3 million in 2024, then plummeted by 40.51% to $5.6 million in 2025, then dropped by 15.2% to $4.7 million in 2026.
  • The last three reported values for Current Deferred Revenue were $4.7 million (Q1 2026), $5.6 million (Q4 2025), and $7.3 million (Q3 2025) per Business Quant data.